The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

In this HotCopper Capital Compass interview, Race Oncology (ASX:RAC) chairman Dr Pete Smith discusses the company’s “safe and successful” Phase One clinical trials and the RC220 plus doxorubicin dosing done at the time.

Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.

Dr Smith told HotCopper about “reformulating” old drugs to put together their RC220 design and how they’ve confirmed recent improving effects.

He also spoke on why working on from an old drug means Race will be “unlikely to face many of the hurdles companies face in terms of the drug working and [safety questions] that often lead to some very expensive studies.”

“We’re excited about unveiling everything as we roll forward,” he added.

Join the discussion: See what HotCopper users are saying about Actinogen Medical Ltd and be part of the conversations that move the markets.

The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.

rac by the numbers
More From The Market Online
The Market Online Video

Market Close: Miners take a beating as ASX slides again

Well, the buyers weren’t exactly lining up to save the day on Thursday.

Pinnacle Minerals accelerates US tungsten strategy with upcoming initial drilling program

Pinnacle Minerals is progressing planning and permitting for an initial drilling program at the Hero tungsten…

Lion Energy obtains “very encouraging” oil indications offshore Indonesia

Lion Energy has obtained promising early results from the Bula Karang-1 exploration well in the East…

High-Tech Metals defines high-grade gold target at Dagger within Damsel gold project

High-Tech Metals has confirmed Dagger as a new gold target within its 100%-owned Mt Fisher gold…